Balaxi Pharmaceuticals
BALAXI · Retail > Trading · MD: Ashish Maheshwari · Listing date: Nov. 30, 2015 · Hyderabad · http://www.balaxiventures.in/

Stock Price vs Company Growth
1d
1.5%
1w
2.7%
1m
7.6%
3m
7.7%
6m
18.4%
1y
47.1%
5y
28.1%
10y
20.4%
all
21.0%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 21.8 1.5%
21
27
Company Overview

Sales
280 Cr
Growth: -3.5%
Profit after Tax
2.42 Cr
Growth: 71.1%
Micro Cap
120 Cr
P/E: 48.4x
Industry P/E: 26.5x
Fundamentals

Sales (Cr) ₹ 280
Growth -3.5%
EBITDA 3.2%
P/S 0.4x
Dividend 0.0%
P/E 48.4x
Book Value ₹ 32.1
PEG Ratio -14.2x
ROE 1.4%
P/B 0.7x
Shareholding Pattern

Institutions
Elara India Opportunities Fund Limited
9.5 %
Marshal Global Capital Fund Ltd
9.5 %
Amol Anand Mantri
1.73 %
Iepf
0.75 %
Promoters
Balaxi Overseas Private Limited
70.0 %
Ashish Maheshwari
1.81 %
Minoshi Maheshwari
1.06 %
Others
Increase    Decrease    No change
Company Profile Detailed

The company is engaged in the business of international wholesale trading of Pharmaceuticals, Builders Hardware and FMCG productsHistory and Milestones2003-07Commenced Pharmaceutcal business by supplying white labeled products to customers in Africa.Sourcing was from WHO GMP certified plants based in India.2008-10Created frontend presence for its Pharmaceutical Business by setting up 1st wholesale depot in Angola in 2008.
Investors (20)
Followers (1)